Andrew Pollack, New York Times; Justices Send Back Gene Case:
"The Supreme Court on Monday ordered an appeals court to reconsider its decision to uphold patents held by Myriad Genetics on two genes associated with a high risk of breast and ovarian cancer.
The appeals court was told to take another look at the case in light of the Supreme Court’s ruling last week that a certain diagnostic test was not eligible for patents because it was a simple application of a law of nature.
The case, Association for Molecular Pathology v. Myriad Genetics, No. 11-725, is being closely watched because it involves the ethically charged but commercially important question of whether genes can be patented."
Issues and developments related to ethics, information, and technologies, examined in the ethics and intellectual property graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology" will be published in Summer 2025. Kip Currier, PhD, JD
Showing posts with label patentability of law of nature. Show all posts
Showing posts with label patentability of law of nature. Show all posts
Tuesday, March 27, 2012
Justices Send Back Gene Case; New York Times, 3/26/12
Subscribe to:
Posts (Atom)